Piya Samankatiwat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Piya Samankatiwat has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Khunthorn Kadeetham
Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
6 shared publications Akeatit Trirattanapikul
Mahidol University Faculty of Medicine Ramathibodi Hospital
2 shared publications- Apichaya Sriprachyakul
Department of Radiology, Stanford University School of Medicine , Stanford, CA, 94305
2 shared publications Bundit Naratreekoon
Mahidol University Faculty of Medicine Ramathibodi Hospital
2 shared publications- Mann Chandavimol
Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
2 shared publications Narongrit Kantathut
Mahidol University Faculty of Medicine Ramathibodi Hospital
2 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (11) , 5111-5115
Risk-adapted first-stage patent ductus arteriosus ligation for an anomalous left brachiocephalic trunk arising from the main pulmonary artery in a critically ill neonate: a case report and literature review
Introduction and importance: Anomalous origin of the brachiocephalic trunk from the main pulmonary artery (MPA) is an exceptionally rare congenital vascular anomaly. Management is not standardized, particularly in critically ill neonates. Case presentation: A female neonate developed acute respiratory distress after birth. Echocardiography showed an atrial septal defect and a patent ductus arteriosus (PDA). Follow-up echocardiography and computed tomography angiography confirmed a right-sided aortic arch, a right-sided PDA, and an anomalous left brachiocephalic trunk arising from the MPA. The course was complicated by active infection, mechanical ventilation, liver cirrhosis, thrombocytopenia, and coagulopathy. After multidisciplinary review, PDA ligation alone was selected as a first-stage stabilization strategy to eliminate the dominant left-to-right shunt. Median sternotomy allowed exposure of the right-sided PDA and great vessels. The PDA was ligated without cardiopulmonary bypass, and the anomalous vessel was preserved. Complete PDA closure and temporary hemodynamic improvement were observed. However, after transfer back to the referring hospital, the patient died before second-stage reconstruction could be performed. Clinical discussion: Reported strategies include vessel ligation and single-stage anatomical repair. In this neonate, definitive reconstruction was deferred because of severe systemic comorbidities and poor physiological reserve. PDA ligation may provide temporary hemodynamic stabilization in critically ill neonates; however, it did not correct the anomalous vascular anatomy or establish long-term perfusion of the cerebral circulation and the left upper extremity. Conclusion: Treatment should be individualized according to physiological reserve. PDA ligation alone may be considered as a temporary, risk-adapted first-stage stabilization in selected high-risk neonates when complete correction is unsafe.
- 14 October 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (11) , 5111-5115
Open AccessRisk-adapted first-stage patent ductus arteriosus ligation for an anomalous left brachiocephalic trunk arising from the main pulmonary artery in a critically ill neonate: a case report and literature review
Introduction and importance: Anomalous origin of the brachiocephalic trunk from the main pulmonary artery (MPA) is an exceptionally rare congenital vascular anomaly. Management is not standardized, particularly in critically ill neonates. Case presentation: A female neonate developed acute respiratory distress after birth. Echocardiography showed an atrial septal defect and a patent ductus arteriosus (PDA). Follow-up echocardiography and computed tomography angiography confirmed a right-sided aortic arch, a right-sided PDA, and an anomalous left brachiocephalic trunk arising from the MPA. The course was complicated by active infection, mechanical ventilation, liver cirrhosis, thrombocytopenia, and coagulopathy. After multidisciplinary review, PDA ligation alone was selected as a first-stage stabilization strategy to eliminate the dominant left-to-right shunt. Median sternotomy allowed exposure of the right-sided PDA and great vessels. The PDA was ligated without cardiopulmonary bypass, and the anomalous vessel was preserved. Complete PDA closure and temporary hemodynamic improvement were observed. However, after transfer back to the referring hospital, the patient died before second-stage reconstruction could be performed. Clinical discussion: Reported strategies include vessel ligation and single-stage anatomical repair. In this neonate, definitive reconstruction was deferred because of severe systemic comorbidities and poor physiological reserve. PDA ligation may provide temporary hemodynamic stabilization in critically ill neonates; however, it did not correct the anomalous vascular anatomy or establish long-term perfusion of the cerebral circulation and the left upper extremity. Conclusion: Treatment should be individualized according to physiological reserve. PDA ligation alone may be considered as a temporary, risk-adapted first-stage stabilization in selected high-risk neonates when complete correction is unsafe.
- Open Access
- 27 April 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (1) , 418-422
Hybrid Transcatheter Pulmonary Valve Replacement With SAPIEN S3 Following Right Ventricular Outflow Tract Reduction Using Tricuspid Annuloplasty Rings
We describe a novel variation of hybrid TPVR using a tricuspid annuloplasty ring which can be considered for patients with very large RVOT, short pulmonary artery, and limited vascular access and to avoid the risk of cardiopulmonary bypass. The utilization of Carpentier‐Edwards Physio Tricuspid annuloplasty ring can reduce the size of the RVOT and at the same time the ring served as an effective docking site for the implantation of the SAPIEN S3 (Edwards Lifesciences). All three reported cases showed satisfactory immediate hemodynamic and clinical outcomes as well as at mid‐term follow up.
- 27 April 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (1) , 418-422
Open AccessHybrid Transcatheter Pulmonary Valve Replacement With SAPIEN S3 Following Right Ventricular Outflow Tract Reduction Using Tricuspid Annuloplasty Rings
We describe a novel variation of hybrid TPVR using a tricuspid annuloplasty ring which can be considered for patients with very large RVOT, short pulmonary artery, and limited vascular access and to avoid the risk of cardiopulmonary bypass. The utilization of Carpentier‐Edwards Physio Tricuspid annuloplasty ring can reduce the size of the RVOT and at the same time the ring served as an effective docking site for the implantation of the SAPIEN S3 (Edwards Lifesciences). All three reported cases showed satisfactory immediate hemodynamic and clinical outcomes as well as at mid‐term follow up.
- 25 October 2024
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 16 (1) , 73-82
Outcomes and Risk Factors for Morbidity and Mortality of Systemic-to-Pulmonary Shunts in a Tertiary Hospital in Thailand
Objectives: A systemic-to-pulmonary shunt is the palliation of choice for many children with cyanotic congenital heart disease. However, significant morbidity and mortality related to these procedures and the postoperative course still exists. We aim to report our outcomes of systemic-to-pulmonary shunts as well as to define certain risk factors for adverse events. Materials and Methods: We retrospectively collected data from the electronic medical records of Ramathibodi hospital from January 01, 2013, to April 30, 2024. Demographic data, operative, and postoperative details were collected and reviewed. Inclusion criteria included patients whose primary operation was a systemic-to-pulmonary shunt. Exclusion criteria were patients diagnosed with hypoplastic left heart syndrome and whose medical record data were missing significant information. Results: There were initially 56 patients eligible for our study. After exclusion, the total number of patients enrolled was 42. Overall the results were excellent, with only one operative mortality, no discharge mortality, and four reinterventions. Outcomes between different shunt types, shunt sizes, surgical approaches, and diagnoses were statistically similar. Conclusions: We demonstrate that systemic-to-pulmonary shunts are a safe and reliable procedure based on our results at a tertiary hospital in Thailand. We emphasize meticulous surgical techniques as well as utilization of proper and reproducible postoperative care protocols to optimize patient outcomes.
- 25 October 2024
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 16 (1) , 73-82
Outcomes and Risk Factors for Morbidity and Mortality of Systemic-to-Pulmonary Shunts in a Tertiary Hospital in Thailand
Objectives: A systemic-to-pulmonary shunt is the palliation of choice for many children with cyanotic congenital heart disease. However, significant morbidity and mortality related to these procedures and the postoperative course still exists. We aim to report our outcomes of systemic-to-pulmonary shunts as well as to define certain risk factors for adverse events. Materials and Methods: We retrospectively collected data from the electronic medical records of Ramathibodi hospital from January 01, 2013, to April 30, 2024. Demographic data, operative, and postoperative details were collected and reviewed. Inclusion criteria included patients whose primary operation was a systemic-to-pulmonary shunt. Exclusion criteria were patients diagnosed with hypoplastic left heart syndrome and whose medical record data were missing significant information. Results: There were initially 56 patients eligible for our study. After exclusion, the total number of patients enrolled was 42. Overall the results were excellent, with only one operative mortality, no discharge mortality, and four reinterventions. Outcomes between different shunt types, shunt sizes, surgical approaches, and diagnoses were statistically similar. Conclusions: We demonstrate that systemic-to-pulmonary shunts are a safe and reliable procedure based on our results at a tertiary hospital in Thailand. We emphasize meticulous surgical techniques as well as utilization of proper and reproducible postoperative care protocols to optimize patient outcomes.
- 12 October 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (6) , 792-800
Surgery for congenital heart disease in Thailand—lessons to be learnt
Congenital heart disease (CHD) is a significant global health issue affecting millions of children. This manuscript provides a detailed examination of the status of CHD surgery in Thailand, encompassing geographical facts, demographic considerations, the burden of CHD, availability of services, organization of delivery, funding mechanisms, training of surgeons, support services, outcome data, and a glimpse into the future of CHD surgery in the country. Above all, the lessons to be learned are critical to helping CHD surgery programs to be lifelong and sustainable.
- 12 October 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (6) , 792-800
Surgery for congenital heart disease in Thailand—lessons to be learnt
Congenital heart disease (CHD) is a significant global health issue affecting millions of children. This manuscript provides a detailed examination of the status of CHD surgery in Thailand, encompassing geographical facts, demographic considerations, the burden of CHD, availability of services, organization of delivery, funding mechanisms, training of surgeons, support services, outcome data, and a glimpse into the future of CHD surgery in the country. Above all, the lessons to be learned are critical to helping CHD surgery programs to be lifelong and sustainable.
- Open Access
- 29 April 2024
- Published by Wiley
Overcoming Double Jeopardy: Successful Orthotopic Heart Transplant in a Recipient with Bacterial and Fungal Infections
Introduction Heart transplantation is considered an important treatment option for advance heart failure patient who do not respond to medical therapy. However, before surgery, contraindications for heart transplantation should be evaluated. These contraindications may include fixed pulmonary hypertension, active cancer, HIV infection, or active infections with unstable conditions. [1]Infection is a significant concern for patients undergoing heart transplantation include pre- and post-operative period, as it may lead to the risk of severe infections in these patients. In fact, infections are the second leading cause of death after graft rejection within the first 30 days following heart transplantation and the leading cause of death beyond 30 days post transplantation. [2,3] Bacterial infections are significant concern for patients undergoing heart transplantation. According to a study, the incidence of bacterial infections in these patients can be as high as 43.6%. Common causes of infection include pneumonia, bloodstream infections due to the placement of central venous catheters, and infections associated with the use of ventricular assist devices. In the past, the mortality rate from invasive pulmonary aspergillosis in heart transplant patients was as high as 66.7%. However, advancements in medical treatments, including antifungal medications, adjustment of immunosuppressive therapy, and improved surgical techniques, have improve survival in these patients. [4,5] As a result, current medical guidelines recommend treating fungal infections until symptoms, radiological findings, and laboratory tests show improvement before proceeding with heart transplantation. However, there are no specific recommendations for the optimal duration of treatment before emergency heart transplantation or in cases where the patient’s condition requires urgent surgery. [6]
- 29 April 2024
- Published by Wiley
Open AccessOvercoming Double Jeopardy: Successful Orthotopic Heart Transplant in a Recipient with Bacterial and Fungal Infections
Introduction Heart transplantation is considered an important treatment option for advance heart failure patient who do not respond to medical therapy. However, before surgery, contraindications for heart transplantation should be evaluated. These contraindications may include fixed pulmonary hypertension, active cancer, HIV infection, or active infections with unstable conditions. [1]Infection is a significant concern for patients undergoing heart transplantation include pre- and post-operative period, as it may lead to the risk of severe infections in these patients. In fact, infections are the second leading cause of death after graft rejection within the first 30 days following heart transplantation and the leading cause of death beyond 30 days post transplantation. [2,3] Bacterial infections are significant concern for patients undergoing heart transplantation. According to a study, the incidence of bacterial infections in these patients can be as high as 43.6%. Common causes of infection include pneumonia, bloodstream infections due to the placement of central venous catheters, and infections associated with the use of ventricular assist devices. In the past, the mortality rate from invasive pulmonary aspergillosis in heart transplant patients was as high as 66.7%. However, advancements in medical treatments, including antifungal medications, adjustment of immunosuppressive therapy, and improved surgical techniques, have improve survival in these patients. [4,5] As a result, current medical guidelines recommend treating fungal infections until symptoms, radiological findings, and laboratory tests show improvement before proceeding with heart transplantation. However, there are no specific recommendations for the optimal duration of treatment before emergency heart transplantation or in cases where the patient’s condition requires urgent surgery. [6]
- Open Access
- 11 April 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (8) , 1693-1700
Impact of right ventriculotomy on cardiac function after pulmonary valve sparing repair of tetralogy of Fallot and double outlet right ventricle with pulmonary stenosis
Objectives: Pulmonary valve-sparing repair of tetralogy of Fallot and double outlet right ventricle with pulmonary stenosis has the advantage of reduced incidence of late pulmonary valve regurgitation and better-preserved cardiac function. However, a right ventriculotomy is sometimes necessary in order to adequately relieve subvalvular pulmonary stenosis. We aimed to compare postoperative cardiac function and patients’ symptoms between pulmonary valve-sparing repair with and without right ventriculotomy.Materials and Methods: We retrospectively collected data from electronic medical records of Ramathibodi Hospital from 1st January 2013 to 31st October 2023. Patients diagnosed with tetralogy of Fallot and double outlet right ventricle with pulmonary stenosis who underwent pulmonary valve-sparing repair were included. Patients who underwent other types of repairs and whose medical record data were significantly missing were excluded. Demographic data, operative, and postoperative details were collected and reviewed.Results: There were 49 patients included in our study with 10 patients undergoing pulmonary valve-sparing repair with and the other 39 without right ventriculotomy. Before-discharge echocardiographic parameters were generally similar between both groups (tricuspid annular plane systolic excursion = 0.9 versus 0.89 cm, P = 0.737; pressure gradient across pulmonary valve across pulmonary valve = 24 versus 19 mmHg, P = 0.275; left ventricular end-systolic volume index = 17.84 versus 19.19 ml/m2, P = 0.437; left ventricular end-diastolic volume index = 63.79 versus 61.13 ml/m2, P = 0.436). Patients’ symptoms were also not statistically different. There was no early and late death up to the end date of our study.Conclusions: Right ventriculotomy in pulmonary valve-sparing repair did not result in worse postoperative cardiac function and symptoms. This suggested that the previously thought-to-be hazardous incision could be strongly considered if mandated.
- 11 April 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (8) , 1693-1700
Open AccessImpact of right ventriculotomy on cardiac function after pulmonary valve sparing repair of tetralogy of Fallot and double outlet right ventricle with pulmonary stenosis
Objectives: Pulmonary valve-sparing repair of tetralogy of Fallot and double outlet right ventricle with pulmonary stenosis has the advantage of reduced incidence of late pulmonary valve regurgitation and better-preserved cardiac function. However, a right ventriculotomy is sometimes necessary in order to adequately relieve subvalvular pulmonary stenosis. We aimed to compare postoperative cardiac function and patients’ symptoms between pulmonary valve-sparing repair with and without right ventriculotomy.Materials and Methods: We retrospectively collected data from electronic medical records of Ramathibodi Hospital from 1st January 2013 to 31st October 2023. Patients diagnosed with tetralogy of Fallot and double outlet right ventricle with pulmonary stenosis who underwent pulmonary valve-sparing repair were included. Patients who underwent other types of repairs and whose medical record data were significantly missing were excluded. Demographic data, operative, and postoperative details were collected and reviewed.Results: There were 49 patients included in our study with 10 patients undergoing pulmonary valve-sparing repair with and the other 39 without right ventriculotomy. Before-discharge echocardiographic parameters were generally similar between both groups (tricuspid annular plane systolic excursion = 0.9 versus 0.89 cm, P = 0.737; pressure gradient across pulmonary valve across pulmonary valve = 24 versus 19 mmHg, P = 0.275; left ventricular end-systolic volume index = 17.84 versus 19.19 ml/m2, P = 0.437; left ventricular end-diastolic volume index = 63.79 versus 61.13 ml/m2, P = 0.436). Patients’ symptoms were also not statistically different. There was no early and late death up to the end date of our study.Conclusions: Right ventriculotomy in pulmonary valve-sparing repair did not result in worse postoperative cardiac function and symptoms. This suggested that the previously thought-to-be hazardous incision could be strongly considered if mandated.
- Open Access
- 1 January 2024
- Published by Wiley in Case Reports in Cardiology
- Vol. 2024 (1)
Overcoming Double Jeopardy: Successful Orthotopic Heart Transplant in a Recipient With Bacterial and Fungal Infections
Although active infection is generally a contraindication before an orthotopic heart transplant, a 16‐year‐old man diagnosed with dilated cardiomyopathy successfully underwent an orthotopic heart transplant despite having active probable invasive pulmonary aspergillosis and bacterial pneumonia in the presence of septic and cardiogenic shock.
- 1 January 2024
- Published by Wiley in Case Reports in Cardiology
- Vol. 2024 (1)
Open AccessOvercoming Double Jeopardy: Successful Orthotopic Heart Transplant in a Recipient With Bacterial and Fungal Infections
Although active infection is generally a contraindication before an orthotopic heart transplant, a 16‐year‐old man diagnosed with dilated cardiomyopathy successfully underwent an orthotopic heart transplant despite having active probable invasive pulmonary aspergillosis and bacterial pneumonia in the presence of septic and cardiogenic shock.
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 2024 (1)
Postoperative Serum Procalcitonin Level Can Be a Useful Marker of Bacterial Infection after Cardiac Surgery Utilizing Cardiopulmonary Bypass
Objectives. Procalcitonin level is generally undetectable from blood sample under normal physiological condition. However, its production can be greatly stimulated by the presence of various inflammatory responses, especially those caused by bacterial infection. We aimed to determine if postoperative procalcitonin level could be used to predict bacterial infection more promptly than bacterial culture results. Materials and Methods. We performed a retrospective case‐control study by collecting postoperative procalcitonin as well as white blood cell level of patients undergoing cardiac surgery using cardiopulmonary bypass from electronic medical records of Ramathibodi Hospital between 1st January 2019 and 30th June 2023. Patients with pre‐existing inflammatory syndromes or proven bacterial infection, who had been receiving preoperative treatment‐dose antibiotics or steroids, who underwent non‐elective surgery, and whose medical record data were lost or insufficiently recorded were excluded. Demographic data and operative details were also collected and reviewed. Results. From a total of 146 patients in our study, 42 patients developed proven postoperative bacterial infection. The level of procalcitonin with greatest association to postoperative bacterial infection from our study was 4.13 ng/dl on postoperative day 7. White blood cell level, however, was less predictive of bacterial infection. Conclusions. Procalcitonin level, when utilized alongside clinical presentation, proved to be useful as a predictor of bacterial infection during postoperative day 7. A larger, prospective trial of our continuing series would further strengthen our results.
- 1 January 2024
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 2024 (1)
Open AccessPostoperative Serum Procalcitonin Level Can Be a Useful Marker of Bacterial Infection after Cardiac Surgery Utilizing Cardiopulmonary Bypass
Objectives. Procalcitonin level is generally undetectable from blood sample under normal physiological condition. However, its production can be greatly stimulated by the presence of various inflammatory responses, especially those caused by bacterial infection. We aimed to determine if postoperative procalcitonin level could be used to predict bacterial infection more promptly than bacterial culture results. Materials and Methods. We performed a retrospective case‐control study by collecting postoperative procalcitonin as well as white blood cell level of patients undergoing cardiac surgery using cardiopulmonary bypass from electronic medical records of Ramathibodi Hospital between 1st January 2019 and 30th June 2023. Patients with pre‐existing inflammatory syndromes or proven bacterial infection, who had been receiving preoperative treatment‐dose antibiotics or steroids, who underwent non‐elective surgery, and whose medical record data were lost or insufficiently recorded were excluded. Demographic data and operative details were also collected and reviewed. Results. From a total of 146 patients in our study, 42 patients developed proven postoperative bacterial infection. The level of procalcitonin with greatest association to postoperative bacterial infection from our study was 4.13 ng/dl on postoperative day 7. White blood cell level, however, was less predictive of bacterial infection. Conclusions. Procalcitonin level, when utilized alongside clinical presentation, proved to be useful as a predictor of bacterial infection during postoperative day 7. A larger, prospective trial of our continuing series would further strengthen our results.
- Open Access
- 15 September 2023
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 18 (1) , 1-13
Heterotopically-placed right ventricle-to-pulmonary artery conduit does not negatively affect outcomes
Since the introduction of surgical implantation of conduit for right ventricle-to-pulmonary artery pathway reconstruction, there has been a number of studies on possible factors which might potentially affect conduit longevity, as well as patient’s reintervention-free and overall survival. Still, no definite consensual agreement could be made thus far. We aimed to compare conduit longevity, reintervention-free survival, and overall survival between patients with congenital heart diseases indicated for operations involving right ventricle-to-pulmonary artery pathway reconstruction whose conduits were placed heterotopically to those with orthotopically placed ones. We retrospectively collected data from electronic medical records of Ramathibodi hospital from 1st January 2005 to 31st December 2022. Patients with congenital heart diseases whose operations involved reconstruction of right ventricle-to-pulmonary artery continuity were included. Patients whose medical record data were significantly missing were excluded. Demographic data, operative, and postoperative details were collected and reviewed. There were 67 patients included in our study, with 25 receiving orthotopic and the other 42 receiving heterotopic conduit implantation. Conduit dysfunction-free, reintervention-free, and overall survival were not statistically different between both groups. There was 1 early and no late death up to the end date of our study. Conduits placed on a heterotopic position did not result in worse longevity, reintervention-free survival, as well as overall survival when compared to conduits placed on an orthotopic position. This suggested that the less technically demanding heterotopic conduit placement could be recommended as an operation of choice for right ventricular outflow tract reconstruction.
- 15 September 2023
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 18 (1) , 1-13
Open AccessHeterotopically-placed right ventricle-to-pulmonary artery conduit does not negatively affect outcomes
Since the introduction of surgical implantation of conduit for right ventricle-to-pulmonary artery pathway reconstruction, there has been a number of studies on possible factors which might potentially affect conduit longevity, as well as patient’s reintervention-free and overall survival. Still, no definite consensual agreement could be made thus far. We aimed to compare conduit longevity, reintervention-free survival, and overall survival between patients with congenital heart diseases indicated for operations involving right ventricle-to-pulmonary artery pathway reconstruction whose conduits were placed heterotopically to those with orthotopically placed ones. We retrospectively collected data from electronic medical records of Ramathibodi hospital from 1st January 2005 to 31st December 2022. Patients with congenital heart diseases whose operations involved reconstruction of right ventricle-to-pulmonary artery continuity were included. Patients whose medical record data were significantly missing were excluded. Demographic data, operative, and postoperative details were collected and reviewed. There were 67 patients included in our study, with 25 receiving orthotopic and the other 42 receiving heterotopic conduit implantation. Conduit dysfunction-free, reintervention-free, and overall survival were not statistically different between both groups. There was 1 early and no late death up to the end date of our study. Conduits placed on a heterotopic position did not result in worse longevity, reintervention-free survival, as well as overall survival when compared to conduits placed on an orthotopic position. This suggested that the less technically demanding heterotopic conduit placement could be recommended as an operation of choice for right ventricular outflow tract reconstruction.